![]() |
市場調查報告書
商品編碼
1729499
日本胰島素幫浦市場報告(按產品類型(胰島素幫浦、胰島素幫浦耗材及配件)、配銷通路(醫院藥局、零售藥局、線上銷售、糖尿病診所/中心等)和地區)2025 年至 2033 年Japan Insulin Pumps Market Report by Product Type (Insulin Pumps, Insulin Pumps Supplies and Accessories), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales, Diabetes Clinics/Centers, and Others), and Region 2025-2033 |
2024 年,日本胰島素幫浦市場規模達 3.312 億美元。展望未來, IMARC Group預計到 2033 年市場規模將達到 5.455 億美元,2025-2033 年期間的成長率 (CAGR) 為 5.7%。糖尿病盛行率的不斷上升、人們對胰島素幫浦的偏好日益增加(而非傳統的胰島素注射)、技術的快速進步、老年人口的增加以及對研發 (R&D) 活動的重視程度的提高是推動市場發展的一些關鍵因素。
胰島素幫浦是一種輸送胰島素到糖尿病患者的小型電子設備。它們通常佩戴在外部,要么在腰帶上,要么放在口袋裡,並通過稱為輸液器的細管連接到身體。幫浦持續輸送胰島素,模仿健康胰臟的功能。與傳統的胰島素注射相比,胰島素幫浦提供了更靈活、更精確的胰島素注射方式。它們既可以輸送基礎胰島素(即持續釋放少量胰島素以控制兩餐之間和睡眠期間的血糖水平),也可以輸送推注胰島素(即餐前注射較大劑量的胰島素以彌補餐後血糖的升高)。
推動日本胰島素幫浦市場發展的主要因素之一是糖尿病盛行率的不斷上升。胰島素幫浦在胰島素輸送方面提供了更大的便利性、靈活性和精確度,有助於改善血糖控制、減少低血糖發作並提高許多醣尿病患者的整體生活品質。同時,由於胰島素幫浦提供的便利性和生活方式的益處,人們對胰島素幫浦的偏好日益高於傳統的胰島素注射,這是另一個促進成長的因素。此外,日本政府實施各種舉措,為包括糖尿病管理在內的各種醫療治療提供保障,為市場創造了積極的前景。除此之外,胰島素幫浦技術的不斷進步,例如整合連續血糖監測 (CGM) 系統的智慧型幫浦的開發,為患者提供更高的準確性、易用性和更好的血糖控制,為市場成長提供了相當大的推動力。此外,大眾對胰島素幫浦的好處和正確的糖尿病管理的認知不斷提高,推動了市場的成長。此外,微創(MI)醫療技術的成長趨勢與胰島素幫浦的吸引力一致,胰島素幫浦僅在輸液器更換時插入針頭,從而促進了市場的成長。其他因素,包括醫療保健行業的顯著成長、消費者支出能力的提高、技術的快速進步、老年人口的增加、對研發活動的重視程度的提高以及對有效和便捷的糖尿病管理解決方案的需求不斷成長,都為市場帶來了有利可圖的成長機會。
The Japan insulin pumps market size reached USD 331.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 545.5 Million by 2033, exhibiting a growth rate (CAGR) of 5.7% during 2025-2033. The increasing prevalence of diabetes, the rising preference for insulin pumps over traditional insulin injections, rapid technological advancements, increasing geriatric population, and enhanced focus on research and development (R&D) activities represent some of the key factors driving the market.
Insulin pumps are small electronic devices that deliver insulin to individuals with diabetes. They are typically worn externally, either on a belt or in a pocket, and are connected to the body through a thin tube called an infusion set. The pump delivers insulin continuously, mimicking the function of a healthy pancreas. As compared to traditional insulin injections, insulin pumps offer a more flexible and precise way of administering insulin. They can deliver both basal insulin, which is a small amount of insulin continuously released to control blood sugar levels between meals and during sleep, as well as bolus insulin, which is a larger dose of insulin taken before meals to cover the rise in blood sugar after eating.
One of the major factors driving the Japan insulin pumps market is the increasing prevalence of diabetes. Insulin pumps offer greater convenience, flexibility, and precision in insulin delivery and help improve blood sugar control, reduce hypoglycemia (low blood sugar) episodes, and enhance the overall quality of life for many individuals with diabetes. In line with this, the rising preference for insulin pumps over traditional insulin injections due to the convenience and lifestyle benefits they offer is acting as another growth-inducing factor. Moreover, the implementation of various initiatives by the Japanese government to provide coverage for various medical treatments, including diabetes management, is creating a positive outlook for the market. Apart from this, continuous technological advancements in insulin pumps, such as the development of smart pumps with integrated continuous glucose monitoring (CGM) systems that offer improved accuracy, ease of use, and better glycemic control for patients is providing a considerable boost to the market growth. Furthermore, the increasing awareness about the benefits of insulin pumps and proper diabetes management among the masses is propelling the market growth. Additionally, the growing trend toward minimally invasive (MI) medical technologies aligns with the appeal of insulin pumps, which involve needle insertion only during the infusion set change is contributing to the market growth. Other factors, including significant growth in the healthcare industry, rising expenditure capacities of consumers, rapid technological advancements, increasing geriatric population, enhanced focus on research and development (R&D) activities, and growing demand for effective and convenient diabetes management solutions, are presenting remunerative growth opportunities for the market.